Table II.

COVID19 patients who had emergency surgery for acute thrombosis of lower limb arteries

Surgery	Age/sex	Comorbidities	Oxygen therapy	CRP (mg/dL)	Discharge conditions
Survival with arterial patency
1–Embolectomy iliac-femoral-popliteal + iliac stenting	81/F	3	Y/high flow	1.3 (A) 0.3 (B) 0.3 (C)	Arterial patency improved general conditions
2–Embolectomy iliac-femoral-popliteal + popliteal PTA	82/M	4	Y/high flow	2.6 (A) 0.6 (B) 0.5 (C)	Arterial patency improved general conditions
3–Embolectomy iliac-femoral-popliteal	83/F	3	Y/high flow	1.5 (A) 5.4 (B) 1.0 (C)	Arterial patency improved general conditions
4–Embolectomy iliac-femoral-popliteal	49/M	3	Invasive mechanical ventilation	20 (A) 11 (B) 9 (C)	Arterial patency improved general conditions
Survival with arterial re-thrombosis
5–Embolectomy iliac-femoral-popliteal + popliteal PTA	67/M	3	Noninvasive mechanical ventilation	12 (A) 5.6 (B) 10 (C)	Re-thrombosis 5 days after initial successful surgery. New embolectomy. Amputation. Improved general conditions
No survival
6–Embolectomy iliac-femoral-popliteal	62/M	3	Invasive mechanical ventilation	8 (A) 24 (B) 28 (C)	Re-thrombosis 1 day after initial successful surgery. Died 30 days later (MOF).

(A) Denotes the day after surgery. (B) Denotes the day before surgery. (C) Denotes 2–3 days after surgery.

CRP, C-reactive protein; MOF, multiple organ failure; PTA, percutaneous transluminal angioplasty.